Latest Regulatory Progress News

Page 7 of 48
Memphasys Limited (ASX: MEM) announced an investor webinar and released an updated presentation detailing its transition from early-stage commercialisation to scaling global revenues, highlighting multi-market sales, recurring cartridge revenue, and regulatory progress.
Ada Torres
Ada Torres
7 Apr 2026
Capricorn Metals delivered 30,358 ounces of gold in Q3 FY26 at the Karlawinda Gold Project, aligning with its mine plan and progressing the Karlawinda Expansion Project with peak construction activity.
Maxwell Dee
Maxwell Dee
7 Apr 2026
Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.
Victor Sage
Victor Sage
2 Apr 2026
Infini Resources has finalised drill targets for a maiden 2,500m diamond drilling campaign at its Reynolds Lake and Reitenbach Lake uranium projects, aiming to unlock the potential of a large, underexplored uranium system on the eastern margin of the Athabasca Basin.
Maxwell Dee
Maxwell Dee
31 Mar 2026
Papua New Guinea’s Conservation and Environment Protection Authority has approved an updated Environment Permit for Geopacific Resources’ Woodlark Gold Project, enabling increased throughput and signalling strong government backing ahead of a key feasibility study.
Maxwell Dee
Maxwell Dee
31 Mar 2026
Alterity Therapeutics has secured encouraging regulatory feedback from the FDA on its ATH434 Phase 3 program for Multiple System Atrophy, marking a critical step towards pivotal trial initiation.
Ada Torres
Ada Torres
30 Mar 2026
Native Mineral Resources has successfully poured 560 ounces of gold doré at its Blackjack plant and is on track to begin mining at Podosky in April, advancing multiple projects in Queensland.
Maxwell Dee
Maxwell Dee
26 Mar 2026
Nexsen Limited is advancing its rapid Group B Streptococcus test, StrepSure®, with a clear FDA submission timeline and early market entries across Asia-Pacific and emerging regions.
Ada Torres
Ada Torres
26 Mar 2026
Eve Health Group is advancing its proprietary reformulation platform with two fast-onset products launched under Australia's SAS-B pathway, targeting large underserved markets in women's and men's health. The company’s capital-light, partner-led model aims for rapid revenue growth post-ARTG registration.
Ada Torres
Ada Torres
26 Mar 2026
Greenwing Resources has launched a Pre-Feasibility Study to refine its plan for restarting mining at Que River, Tasmania, while exploring a novel data infrastructure opportunity on site.
Maxwell Dee
Maxwell Dee
25 Mar 2026
Sentinel Metals has reached a pivotal regulatory milestone as its Columbia Gold-Silver Project’s exploration amendment enters the public comment phase, paving the way for maiden drilling expected in April 2026.
Maxwell Dee
Maxwell Dee
23 Mar 2026
Nexsen Limited has successfully completed a pivotal FDA Pre-Submission meeting for its StrepSure® diagnostic, significantly reducing regulatory risks and advancing its entry into the large US maternal health market.
Ada Torres
Ada Torres
23 Mar 2026